Wellington Management Group LLP Acquires New Stake in Ambiq Micro, Inc. $AMBQ

Key Points

• Wellington Management acquired 168,139 Ambiq Micro shares worth approximately $14.8 million, representing about 0.70% of the company. Other institutions, including Vanguard, also established new positions.
• Analyst sentiment is mixed: three analysts rate the stock Buy, four rate it Hold, and one rates it Sell. The consensus rating is Hold, with an average price target of $82.20.
• Ambiq Micro reported a quarterly loss of $0.07 per share on $33.9 million in revenue, while insiders sold 156,500 shares worth about $9.1 million over the past 90 days. Shares opened at $57.66, well below the 52-week high of $91.61.

Wellington Management Group LLP purchased a new stake in shares of Ambiq Micro, Inc. (NYSE:AMBQ - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 168,139 shares of the company's stock, valued at approximately $14,847,000. Wellington Management Group LLP owned approximately 0.70% of Ambiq Micro at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in AMBQ. Rhumbline Advisers bought a new position in shares of Ambiq Micro in the third quarter valued at approximately $119,000. JPMorgan Chase & Co. purchased a new position in Ambiq Micro in the 3rd quarter worth approximately $56,000. Vanguard Group Inc. bought a new position in shares of Ambiq Micro in the 3rd quarter worth $9,210,000. Franklin Resources Inc. purchased a new stake in shares of Ambiq Micro during the 3rd quarter valued at $358,000. Finally, BNP Paribas Financial Markets purchased a new stake in shares of Ambiq Micro during the 3rd quarter valued at $28,000.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Roth Capital assumed coverage on shares of Ambiq Micro in a research report on Monday, July 13th. They issued a "buy" rating and a $125.00 target price for the company. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Ambiq Micro in a research note on Monday, June 29th. Northland Securities set a $81.00 target price on Ambiq Micro in a research note on Wednesday, August 12th. UBS Group set a $85.00 target price on Ambiq Micro in a research note on Wednesday, August 12th. Finally, Needham & Company LLC upped their price target on shares of Ambiq Micro from $70.00 to $85.00 and gave the company a "buy" rating in a report on Wednesday, August 12th. Three investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Ambiq Micro presently has an average rating of "Hold" and an average price target of $82.20.

Insider Buying and Selling

In other news, CTO Scott Hanson sold 27,500 shares of the firm's stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $59.80, for a total transaction of $1,644,500.00. Following the completion of the transaction, the chief technology officer directly owned 221,226 shares in the company, valued at $13,229,314.80. This trade represents a 11.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Fumihide Esaka sold 48,973 shares of Ambiq Micro stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $56.39, for a total value of $2,761,587.47. Following the completion of the transaction, the chief executive officer directly owned 460,460 shares of the company's stock, valued at approximately $25,965,339.40. This represents a 9.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 156,500 shares of company stock valued at $9,136,973. 10.00% of the stock is owned by corporate insiders.

Ambiq Micro Price Performance

NYSE:AMBQ opened at $57.66 on Tuesday. Ambiq Micro, Inc. has a 1-year low of $22.12 and a 1-year high of $91.61. The company has a market capitalization of $1.39 billion, a PE ratio of -27.20 and a beta of 5.58. The firm's 50-day moving average price is $68.65 and its 200-day moving average price is $56.17.

Ambiq Micro (NYSE:AMBQ - Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported ($0.07) EPS for the quarter. Ambiq Micro had a negative return on equity of 11.85% and a negative net margin of 37.77%.The business had revenue of $33.90 million for the quarter. Ambiq Micro has set its Q3 2026 guidance at -0.200--0.120 EPS. Equities analysts anticipate that Ambiq Micro, Inc. will post -1.16 EPS for the current fiscal year.

Ambiq Micro Company Profile

Ambiq Micro NYSE: AMBQ is a semiconductor company specializing in the design and development of ultra-low-power microcontroller units (MCUs) and application-specific integrated circuits (ASICs). The company's core technology leverages sub-threshold voltage operation to dramatically reduce energy consumption, enabling extended battery life in a broad range of portable and always-on devices. Ambiq's products are particularly well suited for applications where power efficiency is critical, such as wearable electronics, IoT sensors, medical monitoring equipment, and industrial automation systems.

The company's flagship product family, the Apollo series of MCUs, offers multi-core architectures, integrated wireless connectivity options, and advanced security features.

Want to see what other hedge funds are holding AMBQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambiq Micro, Inc. (NYSE:AMBQ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.